XY

Xiangyang YE

HC Hangzhou Innogate Pharma Co.: 2 patents #2 of 3Top 70%
Overall (2022): #97,177 of 548,613Top 20%
2
Patents 2022

Issued Patents 2022

Showing 1–2 of 2 patents

Patent #TitleCo-InventorsDate
11352353 Heterocyclic compound serving as FGFR4 inhibitor Hancheng ZHANG, Shifeng Liu 2022-06-07
11266640 Polycyclic compound acting as IDO inhibitor and/or IDO-HDAC dual inhibitor Hancheng ZHANG 2022-03-08